Research Paper Volume 13, Issue 3 pp 4696—4712

Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma

ARID1A, CSMD1, and SENP3 expression differed significantly between tumor and paracarcinoma tissues. The IHC assay images of ARID1A (A, B), CSMD1 (C, D), and SENP3 (E, F) expression. Left images are tumor tissues (A, C, E) and right images are paracarcinoma tissues (B, D, F). (G) The positive expression rates of ARID1A, CSMD1, and SENP3 in tumor and paracarcinoma tissues. (H) The staining intensity of ARID1A, CSMD1, and SENP3 in tumor and paracarcinoma tissues. (I) The staining intensity × positive expression rate of ARID1A, CSMD1, and SENP3 in tumor and paracarcinoma tissues. Immunofluorescence staining, ×200. A paired-samples t-test was performed to test the difference between tumor and paracarcinoma tissues. Data are shown as mean ± SD. **, P

Figure 3. ARID1A, CSMD1, and SENP3 expression differed significantly between tumor and paracarcinoma tissues. The IHC assay images of ARID1A (A, B), CSMD1 (C, D), and SENP3 (E, F) expression. Left images are tumor tissues (A, C, E) and right images are paracarcinoma tissues (B, D, F). (G) The positive expression rates of ARID1A, CSMD1, and SENP3 in tumor and paracarcinoma tissues. (H) The staining intensity of ARID1A, CSMD1, and SENP3 in tumor and paracarcinoma tissues. (I) The staining intensity × positive expression rate of ARID1A, CSMD1, and SENP3 in tumor and paracarcinoma tissues. Immunofluorescence staining, ×200. A paired-samples t-test was performed to test the difference between tumor and paracarcinoma tissues. Data are shown as mean ± SD. **, P < 0.05.